Kidney cancer is one of the ten most common cancers both in the United States and worldwide. Until this year, there had not previously been a conference focused on translational studies in the broad and heterogeneous group of kidney cancers. Therefore, a group of researchers, clinicians, and patient advocates dedicated to renal cell carcinoma (RCC) launched the Kidney Cancer Research Summit (KCRS) to spur collaboration and further therapeutic advances in these tumors. This commentary aims to summarize the oral presentations and serve as a record for future iterations of this meeting. The KCRS sessions addressed the tumor microenvironment, novel methods of drug delivery, single cell sequencing strategies, novel immune checkpoint blockade and cellular therapies, predictive biomarkers and rare variants of kidney cancers. In addition, the meeting included 2 sessions to promote scientific mentoring and kidney cancer research collaborations. A subsequent KCRS will be planned for the fall of 2020.
Journal of the National Cancer Institute. 2020 May 02 [Epub ahead of print]
Toni K Choueiri, Michael B Atkins, Ziad Bakouny, Maria I Carlo, Charles G Drake, Eric Jonasch, Payal Kapur, Bryan Lewis, W Marston Linehan, Michael J Mitchell, Sumanta K Pal, Kevin Pels, Susan Poteat, W Kimryn Rathmell, Brian I Rini, Sabina Signoretti, Nizar Tannir, Robert Uzzo, Christopher G Wood, Hans J Hammers
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Georgetown Lombardi Comprehensive Cancer Center, Washington, DC., Memorial Sloan Kettering Cancer Center, New York, NY., Columbia University Medical Center, New York, NY., University of Texas MD Anderson Cancer Center, Houston, TX., University of Texas Southwestern Medical Center, Dallas, TX., KidneyCAN, Philadelphia, PA., National Cancer Institute, National Institutes of Health, Bethesda, MD., Department of Bioengineering, University of Pennsylvania, Philadelphia, PA., City of Hope Comprehensive Cancer Center, Duarte, CA., Vanderbilt University Medical Center, Nashville, TN., Fox Chase Cancer Center, Philadelphia, PA.